Whole genome sequencing analysis of 25 metastatic melanoma samples matched with germline DNA identified phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2 (PREX2) as a significantly mutated gene with mutation frequency of 14% in an extended study of 107 human melanomas. This evidence concerns the gene PREX2 and metastatic melanoma.